Fierce Pharma

DECEMBER 2, 2022

With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker. fkansteiner. Fri, 12/02/2022 - 09:51.

267

267

MedCity News

DECEMBER 2, 2022

From streamlining long-held manual processes to creating entirely new diagnostic devices, new tech is cropping up all over the medtech industry—resulting in a real-world impact on patients’ quality of life.

Patients 128

Patients 128

Fierce Pharma

DECEMBER 2, 2022

UPDATED: GSK, with new trial win, looks to expand PD-1 Jemperli in endometrial cancer. zbecker. Fri, 12/02/2022 - 11:22.

235

235

MedCity News

DECEMBER 2, 2022

Health system leaders believe that improving patient access should be their top priority when strategically planning for 2023, according to a new report from the KLAS Research and UPMC’s Center for Connected Medicine. To improve patient access, respondents agreed that their health systems will need to make changes in three key areas — people, process and technology.

Patients 127

Patients Medicine 127

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Fierce Pharma

DECEMBER 2, 2022

Fierce Pharma Asia—Eisai's lecanemab Alzheimer's debate; BeiGene's Imbruvica showdown; Shionogi's COVID drug nod. aliu. Fri, 12/02/2022 - 08:55.

Pharma 191

Pharma 191

MedCity News

DECEMBER 2, 2022

Lumen sells a handheld device that measures users’ metabolism through breath and connects to an app that helps track goals and provides nutrition coaching. The funding round was led by Pitango Venture Capital, and included participation from Hanwha Group and Resolute Ventures.

123

123

MedCity News

DECEMBER 2, 2022

The lawsuit is one of nine cases throughout the country that TeamHealth has brought against United for alleged underpayments. The other eight cases are still ongoing. .

Physicians 120

Physicians Medical Healthcare Healthcare 120

Fierce Pharma

DECEMBER 2, 2022

Rigel scores green light in AML just 4 months after buying asset from Forma. kdunleavy. Fri, 12/02/2022 - 10:00.

147

147

MedCity News

DECEMBER 2, 2022

FDA’s draft guidances on real-world data do not provide strict requirements for industry stakeholders to abide by, but they offer patient advocacy organizations with a clearer understanding of how to model their registries to have a more substantial impact for their patient communities.

FDA 113

FDA Patients 113

PharmaTech

DECEMBER 2, 2022

QMM is an evolutionary advancement in FDA’s quality management maturity initiative that provides industry with a viable methodology to assess and improve manufacturing quality and supply chain reliability.

Pharmaceutical 98

Pharmaceutical Manufacturing Management 98

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Medico Reach

DECEMBER 2, 2022

To bring effective medicines and Innovations in healthcare industry , a Clinical Research Organization or Contract Research Organization (CRO) are a must for the Biotech, Medtech, and pharma industries. A CRO offers comprehensive support to their efforts to test, examine, refine and market the latest medicines and devices that help in improving Healthcare Industry.

Consulting 98

Consulting Specialization Medicine Medical 98

pharmaphorum

DECEMBER 2, 2022

Enrolling for clinical trials has become more challenging in recent years, with trial competition, increasingly complex protocols, and precision medicine targeting more niche patient populations. This emphasises sponsors’ need for enrolment predictability. The challenge the industry faces, however, is that operational certainty is exacerbated by the impact of global disruptions, such as the effect of COVID-19, natural disasters, and regional conflicts.

Competition 98

Competition Leads Patients Electronics 98

MedCity News

DECEMBER 2, 2022

Check out new developments from Medvantx, Medisafe, Medical Informatics Corp., Journey Biosciences, and GSR Ventures.

Healthcare 123

Healthcare Healthcare Medical 123

European Pharmaceutical Review

DECEMBER 2, 2022

Vaccines Europe has unveiled its first pipeline review of its 15 members companies, with 100 vaccine candidates as of July 2022. . The review revealed a pipeline aimed at tackling current and future challenges, such as antimicrobial resistance (AMR) and respiratory tract infections, through leveraging a wide range of new technology platforms. The data indicated 46 percent of the vaccine candidates target infections that do not have an available vaccine.

Healthcare 94

Healthcare Healthcare Competition Pharmaceutical 94

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

Pharma Pathway

DECEMBER 2, 2022

Intas Pharmaceuticals Ltd-Walk-In Drive for M.Sc (Microbiology) in Quality Control On 7th Dec’ 2022. Job Description. Company Profile: INTAS Pharmaceutical is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. Intas is committed to challenging the unmet medical and societal needs through a comprehensive pharmaceutical value chain spanning across the world.

Pharmaceutical 88

Pharmaceutical Pharma Manufacturing Leads 88

European Pharmaceutical Review

DECEMBER 2, 2022

Pfizer Inc. has announced it will invest over €1.2 billion in its manufacturing site in Grange Castle , Dublin, the company’s biggest expansion investment to date in Ireland. A new facility will be built on the site premises, doubling the capacity for biologics manufacturing at the facility. It is anticipated a further 400-500 roles will be created, bringing the total Pfizer employees in Ireland to around 5,500.

Manufacturing 93

Manufacturing Medicine Networking Medical 93

Pharmaceutical Technology

DECEMBER 2, 2022

India’s Central Drugs Standard Control Organisation (CDSCO) has granted approval for Bharat Biotech’s BBV154 vaccine for treating Covid-19. BBV154 is claimed to be the first intra-nasal vaccine for Covid-19 in the world. It has been approved for restricted use in emergencies for people aged 18 and above in India for the first two-dose schedule and homologous booster doses.

Safety 86

Safety Government Manufacturing Pharmaceutical 86

European Pharmaceutical Review

DECEMBER 2, 2022

Rigel Pharmaceuticals, Inc. has announced the US Food and Drug Administration (FDA) has approved its oral drug Rezlidhia (olutasidenib) for adults with relapsed or refractory (R/R) acute myeloid leukaemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation. The FDA approval was supported by open-label Phase II registrational study data, which showed a twice per day 150mg dose of Rezlidhia facilitated a complete remission (CR) + CRh rate of 35 percent of the 153 patients observed.

FDA 79

FDA Food and Drug Administration Food Patients 79

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

PharmaVoice

DECEMBER 2, 2022

The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.

Healthcare 98

Healthcare Healthcare 98

Copyright Clearance Center

DECEMBER 2, 2022

The post OA Agreement Intelligence: A Collaborative Approach to Innovation appeared first on Copyright Clearance Center.

98

98

pharmaphorum

DECEMBER 2, 2022

A new global prostate cancer awareness campaign developed by biopharmaceutical companies AstraZeneca (AZ) and Merck & Co. (MSD) has just been launched in the US and Canada: ‘Never Miss’ leverages sport – as well as social media activity and an information website – as a way to help men understand their potential risk of developing prostate cancer, opening up the conversation about this sensitive topic: Never miss a game.

Media 72

Media Physicians Patients Medical 72

Copyright Clearance Center

DECEMBER 2, 2022

The post HarperCollins Union Members On Strike appeared first on Copyright Clearance Center.

98

98

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management

PharmaTimes

DECEMBER 2, 2022

Patients and service users routinely struggle to access mental healthcare across the NHS

Healthcare 99

Healthcare Healthcare Patients 99

PharmaTech

DECEMBER 2, 2022

Unique solutions are required to protect inherently unstable messenger RNA.

Management 98

Management Manufacturing 98

PharmaTimes

DECEMBER 2, 2022

Positive scientific opinion by EMA would create pathway for arpraziquantel in African endemic countries

Medicine 85

Medicine 85

pharmaphorum

DECEMBER 2, 2022

Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its phase 3 confirmatory Clarity AD study for early Alzheimer’s disease and published them in the New England Journal of Medicine (NEJM). The full result from Eisai’s large, global phase 3 confirmatory Clarity AD clinical study of lecanemab – an investigational anti-amyloid beta (A?

Medicine 59

Medicine Medical Patients 59

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Cesare Ferrari

DECEMBER 2, 2022

This is the second post about upselling and cross selling where I’ll be talking about how to effectively implement these two often misunderstood tactics. You can check part 1 here to understand the basics. How to effectively upsell and cross sell. 1. Keep customer focus. Active listening is one of the most important skills of an effective sales rep.

Medical sales 52

Medical sales Sales Medical Training 52

Pharma Pathway

DECEMBER 2, 2022

Aspiro Pharma -Walk-In Interviews for Production/ Analytical On 4th Dec’ 2022. Job Description. Greetings from Aspiro Pharma !!! Walk-In Interviews for M.Sc/ B.Pharm/M.Pharm/ ITI/ Diploma in Production/ Analytical Department @ Aspiro Pharma . Department: Production/ Analytical. Position: Officer – Sr. Executive/ Operator-Sr. Operator. Experience: 02 to 10 years.

Pharma 52

Pharma 52

PharmExec

DECEMBER 2, 2022

Agility and better decisions depend on managing risk and gaining insights from data by prioritizing patient and end-user needs. Companies of all sizes, including GSK, Boehringer-Ingelheim, Sanofi, AstraZeneca, and AbbVie, share best practices.

Patients 52

Patients Management 52

Pharma Pathway

DECEMBER 2, 2022

FDC Limited- Openings for Quality Assurance/ Packing Departments-Apply Now. Job Description. Department: Quality Assurance/ Packing. Designation : Officer. Qualification: B.Pharm. Experience: 03 to 05 years. Work Location: Goa. Interested Candidates can Share their CV On anesh.shet@fdcindia.com. FDC Limited- Openings for Quality Assurance/ Packing Departments-Apply Now.

52

52

Advertisement

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

Patients